Patents by Inventor John R. Carran

John R. Carran has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7501429
    Abstract: Methods and compounds useful for the inhibition of convulsive disorders, including epilepsy, are disclosed. The methods and compounds of the invention inhibit or prevent ictogenesis and/or epileptogenesis. Methods for preparing the compounds of the invention are also described.
    Type: Grant
    Filed: April 11, 2002
    Date of Patent: March 10, 2009
    Assignee: Queen's University at Kingston
    Inventors: Donald F. Weaver, Buhendwa Musole Guillain, John R. Carran, Kathryn Jones
  • Patent number: 7268164
    Abstract: Methods and compounds useful for the inhibition of convulsive disorders, including epilepsy, are disclosed. The methods and compounds of the invention inhibit or prevent ictogenesis and epileptogenesis. Methods for preparing the compounds of the invention are also described.
    Type: Grant
    Filed: August 16, 2001
    Date of Patent: September 11, 2007
    Assignee: Queens University at Kingston
    Inventors: Donald E. Weaver, Paul H. Milne, Christopher Y. K. Tan, John R. Carran
  • Patent number: 7153692
    Abstract: The present invention exploits the discovery that amounts of uracil and thymine metabolites, especially ?-aminoisobutyric acid, in various bodily fluids, especially urine, are correlated with the occurrence of epilepsy when compared to matched control subjects. Analytical and diagnostic protocols, including a novel high performance liquid chromatography system, for use in the invention are disclosed.
    Type: Grant
    Filed: April 13, 2005
    Date of Patent: December 26, 2006
    Assignee: Queens University at Kingston
    Inventors: Allyson J. Campbell, Donald F. Weaver, Angela P. Lyon, John R. Carran
  • Patent number: 6930112
    Abstract: Methods and compounds useful for the inhibition of convulsive disorders, including epilepsy, are disclosed. The methods and compounds of the invention inhibit or prevent ictogenesis and epileptogenesis. Methods for preparing the compounds of the invention are also described.
    Type: Grant
    Filed: August 16, 2001
    Date of Patent: August 16, 2005
    Assignee: Queen's University at Kingston
    Inventors: Donald F. Weaver, John R. Carran
  • Publication number: 20030229144
    Abstract: Methods and compounds useful for the inhibition of convulsive disorders, including epilepsy, are disclosed. The methods and compounds of the invention inhibit or prevent ictogenesis and epileptogenesis. Methods for preparing the compounds of the invention are also described.
    Type: Application
    Filed: August 16, 2001
    Publication date: December 11, 2003
    Applicant: Queen's University at Kingston
    Inventors: Donald F. Weaver, Paul H. Milne, Christopher Y.K. Tan, John R. Carran
  • Publication number: 20030194375
    Abstract: Methods and compounds useful for the inhibition of convulsive disorders, including epilepsy, are disclosed. The methods and compounds of the invention inhibit or prevent ictogenesis and/or epileptogenesis. Methods for preparing the compounds of the invention are also described.
    Type: Application
    Filed: October 15, 2002
    Publication date: October 16, 2003
    Applicant: Queen's University at Kingston and Neurochem, Inc.
    Inventors: Donald F. Weaver, Christopher Y.K. Tan, Stephen T. Kim, Xianqi Kong, Lan Wei, John R. Carran
  • Publication number: 20030153584
    Abstract: Methods and compounds useful for the inhibition of convulsive disorders, including epilepsy, are disclosed. The methods and compounds of the invention inhibit or prevent ictogenesis and/or epileptogenesis. Methods for preparing the compounds of the invention are also described.
    Type: Application
    Filed: April 11, 2002
    Publication date: August 14, 2003
    Applicant: Queen's University
    Inventors: Donald F. Weaver, Buhendwa Musole Guillain, John R. Carran, Kathryn Jones
  • Publication number: 20030077833
    Abstract: The present invention exploits the discovery that amounts of uracil and thymine metabolites, especially &bgr;-aminoisobutyric acid, in various bodily fluids, especially urine, are correlated with the occurrence of epilepsy when compared to matched control subjects. Analytical and diagnostic protocols, including a novel high performance liquid chromatography system, for use in the invention are disclosed.
    Type: Application
    Filed: August 16, 2002
    Publication date: April 24, 2003
    Applicant: Queen's University at Kingston
    Inventors: Allyson J. Campbell, Donald F. Weaver, Angela P. Lyon, John R. Carran
  • Publication number: 20020025949
    Abstract: Methods and compounds useful for the inhibition of convulsive disorders, including epilepsy, are disclosed. The methods and compounds of the invention inhibit or prevent ictogenesis and epileptogenesis. Methods for preparing the compounds of the invention are also described.
    Type: Application
    Filed: August 16, 2001
    Publication date: February 28, 2002
    Applicant: Queen's University at Kingston
    Inventors: Donald E. Weaver, John R. Carran
  • Patent number: 6306909
    Abstract: Methods and compounds useful for the inhibition of convulsive disorders, including epilepsy, are disclosed. The methods and compounds of the invention inhibit or prevent ictogenesis and epileptogenesis. Methods for preparing the compounds of the invention are also described.
    Type: Grant
    Filed: March 11, 1998
    Date of Patent: October 23, 2001
    Assignee: Queen's University at Kingston
    Inventors: Donald E. Weaver, Paul H. Milne, Christopher Y. K. Tan, John R. Carran